Bank of America Corporation (BAC): Among the Best Fintech Stocks to Buy in 2025

Yahoo Finance00:37 ET

Bank of America Securities: Raised CSPC PHARMA's Target Price to HKD 5.1, rating "Underperform".

Bank of America Securities released a Research Report stating that CSPC PHARMA (01093) main drugs, namely Diphenylhydantoin, Pegylated Recombinant Human Granulocyte Colony-Stimulating Factor, Doxorubicin, and Paclitaxel, recorded sales in February of 0.368 billion yuan, 0.103 billion yuan, 90.8 million yuan, and 30.7 million yuan respectively, with year-on-year declines of 0.6%, 25.3%, 20.6%, and 16.6%, and a month-on-month decline of 40.5%, 41.8%, 29.7%, and 40.1%. Based on the company's performance in February, Bank of America Securities has adjusted its overall sales forecast for the years up to 2027 by 0.5.

Sina Hong Kong stocks.22:28 ET

Oppenheimer Maintains Bank of America(BAC.US) With Buy Rating, Raises Target Price to $51

Moomoo News17:31 ET · Ratings

Bank of America Options Spot-On: On April 28th, 132.01K Contracts Were Traded, With 3.03 Million Open Interest

Moomoo News16:30 ET

Stick With Quality Amid Stocks' Volatility, Says Morgan Stanley

Seeking Alpha14:40 ET

Bank of America Analyst Ratings

Benzinga13:19 ET · Ratings